Ranjithkumar Rajendran
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis.
Journal: British journal of pharmacology
Published: April 25, 2024
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy.
Journal: Frontiers in molecular medicine
Published: February 21, 2024
The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis.
Journal: British journal of pharmacology
Published: November 15, 2022
Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis.
Journal: International journal of molecular sciences
Published: September 05, 2022
Quantitative Lipidomic Analysis of Takotsubo Syndrome Patients' Serum.
Journal: Frontiers in cardiovascular medicine
Published: October 18, 2021
Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE.
Journal: International journal of molecular sciences
Published: August 05, 2021
Evidence of a Muscle-Brain Axis by Quantification of the Neurotrophic Myokine METRNL (Meteorin-Like Protein) in Human Cerebrospinal Fluid and Serum.
Journal: Journal of clinical medicine
Published: April 29, 2021
Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes.
Journal: Cells
Published: April 06, 2021
FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Journal: Cells
Published: February 24, 2021
Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling.
Journal: Brain pathology (Zurich, Switzerland)
Published: July 30, 2020
Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation.
Journal: Brain pathology (Zurich, Switzerland)
Published: June 24, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026